Anna von Nandelstadh (FI)
Anna von Nandelstadh, MD, is a specialist in geriatrics and Chief Physician at the City of Helsinki’s Geriatric Outpatient Clinic. Her work focuses on memory disorders and cognitive health, and she has extensive clinical experience in the assessment and care of older adults. She holds Special Competence in Memory Diseases and has pursued further specialist training in geriatric psychiatry and forensic psychology. Beyond her clinical work, she is interested in deepening the understanding of memory disorders through the arts.
Elisabeth Stögmann (AT)
[Bio missing]
Eric Westman (SE)
Eric Westman is a professor of Neurogeriatrics at Karolinska Institutet with an engineering background from the Royal Institute of Technology (KTH) in Stockholm. He is the head of the Division for Clinical Geriatrics, and he has his research group within the division. He is also acting/vice head of the Department of Neurobiology, Care Sciences and Society. His research has for many years had a focus on the complexity and heterogeneity in ageing, Alzheimer’s Disease, and related disorders. His research is of an interdisciplinary and translational nature, and spans the fields of ageing, geriatrics, radiology, and image processing. He has over 20 years of experience working with advanced image analysis, statistical methods, and machine learning.
Hanneke Rhodius-Meester (NO/NL)
Hanneke Rhodius-Meester is a Dutch clinical geriatrician. She works both at the Alzheimer Center Amsterdam, and at the Memory Clinic at Ullevål, Oslo University Hospital, combining patient care and research. Her research focus is on digital diagnostic tools in daily clinical practice, aiming to improve diagnosis and care.
Henrik Zetterberg (SE)
Henrik Zetterberg is a Professor of Neurochemistry at the University of Gothenburg, Sweden, the University of Wisconsin, Madison, US, and University College London, UK, and a Clinical Chemist at Sahlgrenska University Hospital in Gothenburg, Sweden. He is Head of the Department of Psychiatry and Neurochemistry at the University of Gothenburg, leads the UK DRI Fluid Biomarker Laboratory at UCL, and is a Key Member of the Hong Kong Center for Neurodegenerative Diseases. He is also an elected member of the Royal Swedish Academy of Sciences and the Royal Swedish Academy of Engineering Sciences (Biotechnology). His main research focus and clinical interest are fluid biomarkers for brain diseases, neurodegenerative diseases in particular.
Laura Parkkinen (UK)
Dr Laura Parkkinen is Professor of Translational Neuropathology at the University of Oxford and Director of the Oxford Brain Bank. Her research focuses on neurodegenerative diseases, biomarkers, protein aggregates, digital pathology and multiomics. She collaborates extensively through national and international research networks, has over 10,000 citations and is actively involved in public engagement.
Minna Raivio (FI)
Minna Raivio is Associate Professor of Geriatrics at the University of Helsinki and a geriatrician at Terveystalo. She leads the first Nordic clinic providing anti-amyloid treatments, building on extensive experience as principal investigator in multinational Alzheimer’s trials since 1997. Her research focuses on Alzheimer’s disease, elderly polypharmacy, rehabilitation and caregivers’ needs.
Sebastian Palmqvist (SE)
Sebastian Palmqvist is a senior consultant neurologist at the Memory Clinic, Skåne University Hospital and associate professor and senior lecturer of neurology at Lund University, Sweden. For 20 years, Dr. Palmqvist’s research has focused on biomarkers and cognitive assessments in Alzheimer’s disease with the aim of improving clinical diagnostics, and he has published over 200 papers. He currently co-leads the BioFINDER studies and he is the co-chair of the Alzheimer’s Association Clinical Practice Guidelines for blood-based biomarkers. Dr. Palmqvist has been recognized as a Highly Cited Researcher by Clarivate yearly since 2022 (top 0.1% citations), based in part on large clinical validation studies on blood-based biomarkers for Alzheimer’s disease published in JAMA and Nature Medicine. His major funding sources include the GHR Foundation, National Institute on Aging, the Alzheimer’s Association, and the Swedish Research Council. He is currently active as a clinician, researcher, teacher, and supervisor.
Tormod Fladby (NO)
Tormod Fladby (MD, PhD) is head of the Department of Neurology, Akershus University Hospital and a professor at the Institute of Clinical Medicine, University of Oslo. His research concerns cognitive impairment in Alzheimer’s disease, biomarkers and imaging diagnostics as well as clinical trials and development of treatments.
